Austco Healthcare Limited (AHC.AX)
AUD 0.27
(0.0%)
AUD 0.27
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 8.11 Million AUD | 125.39% |
| 2023 | 3.6 Million AUD | -0.11% |
| 2022 | 3.52 Million AUD | 12.62% |
| 2021 | 3.12 Million AUD | -14.34% |
| 2020 | 3.65 Million AUD | 554.66% |
| 2019 | 558 Thousand AUD | -64.62% |
| 2018 | 1.57 Million AUD | 269.94% |
| 2017 | -3.67 Million AUD | 70.53% |
| 2016 | -3.12 Million AUD | -334.13% |
| 2015 | 720 Thousand AUD | -65.43% |
| 2014 | 3.89 Million AUD | 145.64% |
| 2013 | 904 Thousand AUD | 63.81% |
| 2012 | 967 Thousand AUD | -13.58% |
| 2011 | -1.86 Million AUD | -17.84% |
| 2010 | -6.99 Million AUD | -42.24% |
| 2009 | -8.51 Million AUD | -46.31% |
| 2008 | 4.38 Million AUD | 43.02% |
| 2007 | 3.01 Million AUD | -5.04% |
| 2006 | 3.23 Million AUD | 89.23% |
| 2005 | 1.7 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.06 Million AUD | 80.59% |
| 2024 Q3 | 2.7 Million AUD | 29.97% |
| 2024 Q4 | 2.56 Million AUD | -5.29% |
| 2024 FY | - AUD | 130.34% |
| 2024 Q1 | 1.15 Million AUD | 8.56% |
| 2023 Q3 | 356.5 Thousand AUD | -85.64% |
| 2023 FY | - AUD | -0.11% |
| 2023 Q2 | 2.48 Million AUD | 86.34% |
| 2023 Q1 | 1.33 Million AUD | -18.7% |
| 2023 Q4 | 1.03 Million AUD | 191.16% |
| 2022 Q4 | 1.63 Million AUD | 141.38% |
| 2022 Q3 | 679 Thousand AUD | -61.96% |
| 2022 Q2 | 1.78 Million AUD | 149.13% |
| 2022 Q1 | 716.5 Thousand AUD | -68.04% |
| 2022 FY | - AUD | 12.62% |
| 2021 Q4 | 2.24 Million AUD | 143.12% |
| 2021 Q3 | 922.16 Thousand AUD | 10.04% |
| 2021 FY | - AUD | -14.34% |
| 2021 Q2 | 838 Thousand AUD | 163.11% |
| 2021 Q1 | 318.5 Thousand AUD | -60.29% |
| 2020 Q3 | 204.5 Thousand AUD | -85.48% |
| 2020 FY | - AUD | 554.66% |
| 2020 Q1 | 626 Thousand AUD | -15.97% |
| 2020 Q2 | 1.4 Million AUD | 124.92% |
| 2020 Q4 | 802 Thousand AUD | 292.18% |
| 2019 Q2 | -177 Thousand AUD | 0.0% |
| 2019 Q3 | 312.5 Thousand AUD | 276.55% |
| 2019 Q4 | 745 Thousand AUD | 138.4% |
| 2019 FY | - AUD | -64.62% |
| 2019 Q1 | -177 Thousand AUD | -135.65% |
| 2018 Q4 | 496.5 Thousand AUD | 0.0% |
| 2018 Q3 | 496.5 Thousand AUD | 76.06% |
| 2018 Q2 | 282 Thousand AUD | 0.0% |
| 2018 Q1 | 282 Thousand AUD | 481.44% |
| 2018 FY | - AUD | 269.94% |
| 2017 Q4 | 48.5 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 70.53% |
| 2017 Q3 | 48.5 Thousand AUD | 104.83% |
| 2017 Q2 | -1 Million AUD | 0.0% |
| 2017 Q1 | -1 Million AUD | 37.54% |
| 2016 Q1 | -307 Thousand AUD | 85.45% |
| 2016 FY | - AUD | -334.13% |
| 2016 Q3 | -1.6 Million AUD | -423.62% |
| 2016 Q2 | -307 Thousand AUD | 0.0% |
| 2016 Q4 | -1.6 Million AUD | 0.0% |
| 2015 Q1 | 565.5 Thousand AUD | 0.0% |
| 2015 Q2 | 565.5 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -65.43% |
| 2015 Q3 | 3500.00 AUD | -99.38% |
| 2015 Q4 | -2.11 Million AUD | -60400.0% |
| 2014 FY | - AUD | 145.64% |
| 2014 Q1 | 1.23 Million AUD | 602.27% |
| 2014 Q2 | 1.23 Million AUD | 0.0% |
| 2013 Q1 | 474 Thousand AUD | 0.0% |
| 2013 Q2 | 474 Thousand AUD | 0.0% |
| 2013 Q4 | 176 Thousand AUD | -13.73% |
| 2013 FY | - AUD | 63.81% |
| 2013 Q3 | 204 Thousand AUD | -56.96% |
| 2012 FY | - AUD | -13.58% |
| 2011 FY | - AUD | -17.84% |
| 2010 FY | - AUD | -42.24% |
| 2009 FY | - AUD | -46.31% |
| 2008 FY | - AUD | 43.02% |
| 2007 FY | - AUD | -5.04% |
| 2006 FY | - AUD | 89.23% |
| 2005 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nanosonics Limited | 21.72 Million AUD | 62.648% |
| Osteopore Limited | -4.34 Million AUD | 286.571% |
| SDI Limited | 20.96 Million AUD | 61.288% |
| Trajan Group Holdings Limited | -20.35 Million AUD | 139.859% |